To estimate the prevalence of changes to the initial treatment regimen of hypertensive patients in a managed care setting. and to identify the factors having the most impact on the cost of treatment. 
RESEARCH OBJECTIVES
This survey was conducted to assess whether multiple changes to antihypertensive drug therapy are present 'within diversified managed care settings and to gather qualitative information that would highlight a possible association between various treatment trends and uncontrolled blood pressure. The primary research objectives of this national survey of HMO pharmacy directors were to estimate the prevalence of changes among hypèrtensive patients who initiated treatment with an angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs). Utilization patterns, specifically related to ACE inhibitors and CCSs, were examined because they have a higher ingredient cost than other antihypertensives. Therefore, secondary goals of this study were to determine concomitancy rates of combined treatment with ACE inhibitors and CCBs to assess the types of changes made to the treatment regimen and to identify the factors having the most impact on the cost of treatment. Finally, the survey was designed to gather the informed opinions of managed care pharmacy directors on specific issues related to antihypertensive drug use. The qualitative data focused on the respondents' major concerns about the current management of hypertension, the degree to which hypertension receives economic scrutiny within their plans, and how' the respondents think the treatment of hypertension could be improved in their plans. ..
RESULTS

Status of Hypertension
